Levodopa vs Nivolumab

## Levodopa vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Levodopa** and **Nivolumab**.

## Mechanism of Action

**Levodopa**: Metabolic precursor of dopamine that crosses the BBB.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Levodopa — 1.5 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Levodopa — C9H11NO4; Nivolumab — N/A.

**Molecular Weight**: Levodopa — 197.1880 g/mol; Nivolumab — N/A.

**Type**: Levodopa — Small molecule; Nivolumab — Antibody.